EXPLORING cancer rates in First Nations communities began yesterday with the launch of the Kulay Kalingka study.
The research led by the Australian National University (ANU) will gather information about First Nations' experiences of cancer where no data currently exists.
Launched at Wiradjuri Condobolin Corporation in Condobolin NSW, the study will fill important gaps in understanding experiences of cancer which is the fourth leading cause of burden of disease for First Nations people.
Funded by the Australian Government, through Cancer Australia, it's the first cancer study designed, governed and controlled by First Nations Australians.
The study is being led by the Aboriginal and Torres Strait Islander research team at the ANU's National Centre for Aboriginal and Torres Strait Islander Wellbeing Research.
The results will also inform the implementation of the soon-to-be-released Australian Cancer Plan.
The collection of up to 3,000 stories told by First Nations people as part of this study will hopefully provide the evidence needed to inform the Government's policies, programs and services to improve cancer outcomes.
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Jul 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Jul 23